Show Quick Read Summary is AI-generated, newsroom-reviewed

The central drug regulator the Central Drugs Standard Control Organisation (CDSCO) has informed the World Health Organisation (WHO) about the halt in the production of Coldrif, Respifresh TR and ReLife, which it has deemed toxic. The CDSCO has also communicated to the the global health agency that none of the three syrups were exported from India. This came in response to the WHO seeking to know from Indian authorities whether the cough syrup linked to children deaths in the country, in parts of Rajasthan and Madhya Pradesh, was exported to other countries or not.

India has declared the three cough syrups as toxic following the deaths of at least 20 children in the past month. While all the deaths have been linked to Coldrif, me

See Full Page